Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Product Unit Size | Cost | Quantity | Stock |
---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Purity | ≥95% |
---|---|
Formula | C18H25N5O5S |
Formula Wt. | 423.4 |
Synonym | MGP-pNa |
Solubility | Soluble in water. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Opioid neuropeptide; kyotorphin agonist.
Trichothecene mycotoxin produced by Fusarium.
Inhibitor of EGFR/HER2 (ErbB2).
Flavonol glycoside originally found in Epimediu...
Cembranoid diterpene found in Sarcophyton glauc...
Mycotoxin produced by Fusarium; sphingosine acy...
Synthetic steroid; glucocorticoid agonist.
T-type Ca2+ and voltage-gated Na+ channel block...
Notch inhibitor.
Statin; HMG-CoA reductase inhibitor, potential ...
CRM1-selective inhibitor of nuclear export.
Potential p53 activator or SIRT2 inhibitor.
Aurora kinase A inhibitor.
Polyphenol found in Gossypium; calcineurin and ...
Steroidal saponin found in Dioscorea.
AT1 inhibitor.
c-MET inhibitor.
Endogenous anionic non-sulfated glycosaminoglyc...
L-type Ca2+ channel blocker, BK K+ channel modu...
ATM and ATR inhibitor.